Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2018

01-10-2018 | Research Article

Community pharmacists’ perspectives on implementation of Medicines Use Review in Slovenia

Authors: Urska Nabergoj Makovec, Mitja Kos, Nina Pisk

Published in: International Journal of Clinical Pharmacy | Issue 5/2018

Login to get access

Abstract

Background In December 2014 Slovene Chamber of Pharmacies defined procedures for Medicines Use Review (MUR) in Slovenia, together with an educational program and certification to ensure pharmacists’ competency to perform MUR. The first 15 pharmacists were certified in June 2015 and implemented the service in their practices. Objective This study aimed to understand the implementation of MUR from the perspectives of the first community pharmacists providing the service in practice. Methods A focus group with first MUR providers took place in February 2016, 6 months after the first pharmacists were certified to provide MUR service. Based on regional and institutional criteria ten pharmacists from the first certified group were chosen and invited to participate in guided discussion, where the development and assurance of competencies, the provision of the service in practice and the future of the service were addressed. The discussion was voice recorded with written consent obtained from all participants. Analysis was performed in NVivo 11 software with the use of inductive qualitative content analysis approach. Main outcome measure Views, challenges and opportunities for the Medicines Use Review service in Slovenia. Results Seven pharmacists attended the focus group, 5 from public pharmaceutical institution and 2 from concessionary pharmacies. Three main thematical categories were identified: quality assurance of MUR, different stakeholders’ perceptions of MUR and MURs’ management. Pharmacists’ broad knowledge in pharmacotherapy was emphasized as the basis of quality provision and main advantage in performing MUR in comparison with other healthcare professions. Recognisability of MUR among different stakeholders should be improved with comprehensive approach in marketing of the service. Positive patient feedback was reported, however persuading them to attend MUR presented a challenge. Better management of the service, especially in terms of work organization, would facilitate MUR provision. Conclusion Overall, positive experiences with implementation and provision were reported. To ensure MUR sustainability, the service needs to become more widely known and opportunities must be provided for continuing professional development of providing pharmacists.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–43. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–43.
2.
go back to reference Allemann SS, van Mil FJW, Botermann L, Berger K, Griese N, Hersberger KE. Pharmaceutical care: the PCNE definition 2013. Int J Clin Pharm. 2014;36(3):544–55.CrossRef Allemann SS, van Mil FJW, Botermann L, Berger K, Griese N, Hersberger KE. Pharmaceutical care: the PCNE definition 2013. Int J Clin Pharm. 2014;36(3):544–55.CrossRef
3.
go back to reference Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Practice change in community pharmacy: quantification of facilitators. Ann Pharmacother. 2008;42(6):861–8.CrossRef Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Practice change in community pharmacy: quantification of facilitators. Ann Pharmacother. 2008;42(6):861–8.CrossRef
4.
go back to reference Saez-Benito L, Fernandez-Llimos F, Feletto E, Gastelurrutia MA, Martinez-Martinez F, Benrimoj SI. Evidence of the clinical effectiveness of cognitive pharmaceutical services for aged patients. Age Ageing. 2013;42(4):442–9.CrossRef Saez-Benito L, Fernandez-Llimos F, Feletto E, Gastelurrutia MA, Martinez-Martinez F, Benrimoj SI. Evidence of the clinical effectiveness of cognitive pharmaceutical services for aged patients. Age Ageing. 2013;42(4):442–9.CrossRef
5.
go back to reference Jokanovic N, Tan EC, Sudhakaran S, Kirkpatrick CM, Dooley MJ, Ryan-Atwood TE, et al. Pharmacist-led medication review in community settings: an overview of systematic reviews. Res Social Adm Pharm. 2017;13(4):661–85.CrossRef Jokanovic N, Tan EC, Sudhakaran S, Kirkpatrick CM, Dooley MJ, Ryan-Atwood TE, et al. Pharmacist-led medication review in community settings: an overview of systematic reviews. Res Social Adm Pharm. 2017;13(4):661–85.CrossRef
6.
go back to reference Hatah E, Braund R, Tordoff J, Duffull SB. A systematic review and meta-analysis of pharmacist-led fee-for-services medication review. Br J Clin Pharmacol. 2014;77(1):102–15.CrossRef Hatah E, Braund R, Tordoff J, Duffull SB. A systematic review and meta-analysis of pharmacist-led fee-for-services medication review. Br J Clin Pharmacol. 2014;77(1):102–15.CrossRef
7.
go back to reference Holland R, Desborough J, Goodyer L, Hall S, Wright D, Loke YK. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol. 2008;65(3):303–16.CrossRef Holland R, Desborough J, Goodyer L, Hall S, Wright D, Loke YK. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol. 2008;65(3):303–16.CrossRef
8.
go back to reference Christensen M, Lundh A. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev. 2013;2:CD008986. Christensen M, Lundh A. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev. 2013;2:CD008986.
9.
go back to reference Blenkinsopp A, Bond C, Raynor DK. Medication reviews. Br J Clin Pharmacol. 2012;74(4):573–80.CrossRef Blenkinsopp A, Bond C, Raynor DK. Medication reviews. Br J Clin Pharmacol. 2012;74(4):573–80.CrossRef
12.
go back to reference Madjar B. Medicines use review [in Slovene]. Lekarnistvo (publication of Slovene Chamber of Pharmacies). 2013;5:63–66. Madjar B. Medicines use review [in Slovene]. Lekarnistvo (publication of Slovene Chamber of Pharmacies). 2013;5:63–66.
13.
go back to reference Madjar B, Pisk N, Knez L. Standard operating procedure for medicines use review [in Slovene]. [Standard operating procedur]. In press 2014. Madjar B, Pisk N, Knez L. Standard operating procedure for medicines use review [in Slovene]. [Standard operating procedur]. In press 2014.
16.
go back to reference Potocnik Bencic D, Bernik Golubic S. Activities in the performance of new pharamceutical cognitive services and education programm to gain competences for Medicines Use Review service. Lekarnistvo (publication of Slovene Chamber of Pharmacies). 2015;4:17–20. Potocnik Bencic D, Bernik Golubic S. Activities in the performance of new pharamceutical cognitive services and education programm to gain competences for Medicines Use Review service. Lekarnistvo (publication of Slovene Chamber of Pharmacies). 2015;4:17–20.
17.
go back to reference Hughes CM, Cadogan CA, Ryan CA. Development of a pharmacy practice intervention: lessons from the literature. Int J Clin Pharm. 2016;38(3):601–6.PubMed Hughes CM, Cadogan CA, Ryan CA. Development of a pharmacy practice intervention: lessons from the literature. Int J Clin Pharm. 2016;38(3):601–6.PubMed
18.
go back to reference Peters DH, Adam T, Alonge O, Agyepong IA, Tran N. Implementation research: what it is and how to do it. BMJ. 2013;347:f6753.CrossRef Peters DH, Adam T, Alonge O, Agyepong IA, Tran N. Implementation research: what it is and how to do it. BMJ. 2013;347:f6753.CrossRef
19.
go back to reference Roberts AS, Benrimoj SI, Chen TF, Williams KA, Hopp TR, Aslani P. Understanding practice change in community pharmacy: a qualitative study in Australia. Res Social Adm Pharm. 2005;1(4):546–64.CrossRef Roberts AS, Benrimoj SI, Chen TF, Williams KA, Hopp TR, Aslani P. Understanding practice change in community pharmacy: a qualitative study in Australia. Res Social Adm Pharm. 2005;1(4):546–64.CrossRef
20.
go back to reference Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65–76.CrossRef Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65–76.CrossRef
21.
go back to reference Giacomini MK, Cook DJ. Users’ guides to the medical literature: XXIII. Qualitative research in health care A. Are the results of the study valid? Evidence-based medicine working group. JAMA. 2000;284(3):357–62.CrossRef Giacomini MK, Cook DJ. Users’ guides to the medical literature: XXIII. Qualitative research in health care A. Are the results of the study valid? Evidence-based medicine working group. JAMA. 2000;284(3):357–62.CrossRef
22.
go back to reference Deticek A, Marđetko N, Horvat N, Kos M. Bright future for pharmacy practice in Slovenia. PCNE Newsl. 2016;11(4):3. Deticek A, Marđetko N, Horvat N, Kos M. Bright future for pharmacy practice in Slovenia. PCNE Newsl. 2016;11(4):3.
23.
go back to reference Priest H, Roberts P, Woods L. An overview of three different approaches to the interpretation of qualitative data. Part 1: theoretical issues. Nurse Res. 2002;10(1):30–42.CrossRef Priest H, Roberts P, Woods L. An overview of three different approaches to the interpretation of qualitative data. Part 1: theoretical issues. Nurse Res. 2002;10(1):30–42.CrossRef
24.
go back to reference NVivo Pro software for qualitative data analysis v11. 11th ed: QSR International Pty Ltd; 2016. NVivo Pro software for qualitative data analysis v11. 11th ed: QSR International Pty Ltd; 2016.
25.
go back to reference Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.CrossRef Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.CrossRef
26.
go back to reference Alexander A. MURs how the picture is developing. Pharm J. 2006;276:44–6. Alexander A. MURs how the picture is developing. Pharm J. 2006;276:44–6.
27.
go back to reference Bradley F, Wagner AC, Elvey R, Noyce PR, Ashcroft DM. Determinants of the uptake of medicines use reviews (MURs) by community pharmacies in England: a multi-method study. Health Policy. 2008;88(2–3):258–68.CrossRef Bradley F, Wagner AC, Elvey R, Noyce PR, Ashcroft DM. Determinants of the uptake of medicines use reviews (MURs) by community pharmacies in England: a multi-method study. Health Policy. 2008;88(2–3):258–68.CrossRef
28.
go back to reference Urban R, Rivers P, Morgan J. Perceptions of medicines use reviews—the views of community pharmacists within a West Yorkshire primary care trust. Pharm J. 2008;281:303–5. Urban R, Rivers P, Morgan J. Perceptions of medicines use reviews—the views of community pharmacists within a West Yorkshire primary care trust. Pharm J. 2008;281:303–5.
29.
go back to reference Blenkinsopp A, Celino G, Bond C, Inch J. Medicines Use Review: the first year of a new community pharmacist service. Pharm J. 2007;278:218–23. Blenkinsopp A, Celino G, Bond C, Inch J. Medicines Use Review: the first year of a new community pharmacist service. Pharm J. 2007;278:218–23.
30.
go back to reference Cowley J, Gidman W, McGregor L, Andoh N. Exploring community pharmacists’ experience and opinions of Medication review services in England, Wales and Scotland. IJPP. 2010;18(Suppl 2):88. Cowley J, Gidman W, McGregor L, Andoh N. Exploring community pharmacists’ experience and opinions of Medication review services in England, Wales and Scotland. IJPP. 2010;18(Suppl 2):88.
31.
go back to reference Latif A, Boardman H. Community pharmacists’ attitudes towards medicines use reviews and factors affecting the numbers performed. Pharm World Sci. 2008;30(5):536–43.CrossRef Latif A, Boardman H. Community pharmacists’ attitudes towards medicines use reviews and factors affecting the numbers performed. Pharm World Sci. 2008;30(5):536–43.CrossRef
32.
go back to reference Latif A, Pollock K, Boardman HF. Medicines use reviews: a potential resource or lost opportunity for general practice? BMC Fam Pract. 2013;14:57.CrossRef Latif A, Pollock K, Boardman HF. Medicines use reviews: a potential resource or lost opportunity for general practice? BMC Fam Pract. 2013;14:57.CrossRef
33.
go back to reference Foulsham R, Saibi N, Nijjer S, Dhillon S. Ready, steady, pause and take stock! Time to reflect on medicines use review. Pharm J. 2006;276:414. Foulsham R, Saibi N, Nijjer S, Dhillon S. Ready, steady, pause and take stock! Time to reflect on medicines use review. Pharm J. 2006;276:414.
34.
go back to reference Rosenbloom EK, Graham J. A review of the implementation of medicines use reviews in Hertfordshire: findings of surveys conducted in 2006 and 2008. IJPP. 2008;16(Suppl 3):C48–9. Rosenbloom EK, Graham J. A review of the implementation of medicines use reviews in Hertfordshire: findings of surveys conducted in 2006 and 2008. IJPP. 2008;16(Suppl 3):C48–9.
35.
go back to reference Bassi M, Wood K. Medicines use reviews: time for a new name? IJPP. 2009;17(Suppl 2):B5–6. Bassi M, Wood K. Medicines use reviews: time for a new name? IJPP. 2009;17(Suppl 2):B5–6.
36.
go back to reference McDonald R, Cheraghi-Sohi S, Sanders C, Ashcroft D. Professional status in a changing world: the case of Medicines Use Reviews in English community pharmacy. Soc Sci Med. 2010;71:451–8.CrossRef McDonald R, Cheraghi-Sohi S, Sanders C, Ashcroft D. Professional status in a changing world: the case of Medicines Use Reviews in English community pharmacy. Soc Sci Med. 2010;71:451–8.CrossRef
37.
go back to reference Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.CrossRef Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.CrossRef
38.
go back to reference Kirk MA, Kelley C, Yankey N, Birken SA, Abadie B, Damschroder L. A systematic review of the use of the consolidated framework for implementation research. Implement Sci. 2016;11:72.CrossRef Kirk MA, Kelley C, Yankey N, Birken SA, Abadie B, Damschroder L. A systematic review of the use of the consolidated framework for implementation research. Implement Sci. 2016;11:72.CrossRef
39.
go back to reference Doucette WR, Nevins JC, Gaither C, Kreling DH, Mott DA, Pedersen CA, et al. Organizational factors influencing pharmacy practice change. Res Social Adm Pharm. 2012;8(4):274–84.CrossRef Doucette WR, Nevins JC, Gaither C, Kreling DH, Mott DA, Pedersen CA, et al. Organizational factors influencing pharmacy practice change. Res Social Adm Pharm. 2012;8(4):274–84.CrossRef
40.
go back to reference Marđetko N, Deticek A, Horvat N, Kos M. From Bismarck to Bismarck—healthcare system in Slovenia. PCNE Newsl. 2016;11(4):3. Marđetko N, Deticek A, Horvat N, Kos M. From Bismarck to Bismarck—healthcare system in Slovenia. PCNE Newsl. 2016;11(4):3.
41.
go back to reference Harding G, Wilcock M. What do pharmacists think of peer review of medicines use reviews? Pharm J. 2008;281:674. Harding G, Wilcock M. What do pharmacists think of peer review of medicines use reviews? Pharm J. 2008;281:674.
42.
go back to reference Harding G, Wilcock M. Community pharmacists’ perceptions of medicines use reviews and quality assurance by peer review. Pharm World Sci. 2010;32:381–5.CrossRef Harding G, Wilcock M. Community pharmacists’ perceptions of medicines use reviews and quality assurance by peer review. Pharm World Sci. 2010;32:381–5.CrossRef
43.
go back to reference Khideja N. Community pharmacists’ experience and perceptions of Medicines Use Review: initial and ongoing training of community pharmacists in the Black Country region—West Midlands. IJPP. 2009;17(Suppl 2):B60. Khideja N. Community pharmacists’ experience and perceptions of Medicines Use Review: initial and ongoing training of community pharmacists in the Black Country region—West Midlands. IJPP. 2009;17(Suppl 2):B60.
44.
go back to reference Connelly D. MURs: achieving the right balance. Pharm J. 2007;278:451. Connelly D. MURs: achieving the right balance. Pharm J. 2007;278:451.
45.
go back to reference Rantucci MJ. The medication management consultation. Pharmacists talking with patients: a guide to patient counseling. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 300. Rantucci MJ. The medication management consultation. Pharmacists talking with patients: a guide to patient counseling. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 300.
46.
go back to reference Beardsley RS, Kimberlin CL, Tindall WN. Barriers to communication (chapter 4). Communication skills in pharmacy practice: a practical guide for students and practitioners. 6th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2013. p. 256. Beardsley RS, Kimberlin CL, Tindall WN. Barriers to communication (chapter 4). Communication skills in pharmacy practice: a practical guide for students and practitioners. 6th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2013. p. 256.
47.
go back to reference Van Mill J, De Boer W, Tromp TH. European barriers to the implementation of pharmaceutical care. IJPP. 2001;9:163–8. Van Mill J, De Boer W, Tromp TH. European barriers to the implementation of pharmaceutical care. IJPP. 2001;9:163–8.
48.
go back to reference McDonald R, Cheraghi-Sohi S, Tickle M. The impact of incentives on the behaviour and performance of primary care professionals. Report for the National Institute for Health Research Service Delivery and Organisation Programme. 2010. McDonald R, Cheraghi-Sohi S, Tickle M. The impact of incentives on the behaviour and performance of primary care professionals. Report for the National Institute for Health Research Service Delivery and Organisation Programme. 2010.
49.
go back to reference Ewen D, Ingram M, MacAdam A. The uptake and perceptions of the medicines use review service by community pharmacists in England and Wales. IJPP. 2006;14(Suppl 2):B51–2. Ewen D, Ingram M, MacAdam A. The uptake and perceptions of the medicines use review service by community pharmacists in England and Wales. IJPP. 2006;14(Suppl 2):B51–2.
50.
go back to reference Hall J, Smith I. Barriers to medicines use reviews: comparing the views of pharmacists and PCTs. IJPP. 2006;14(Suppl 2):B51–2. Hall J, Smith I. Barriers to medicines use reviews: comparing the views of pharmacists and PCTs. IJPP. 2006;14(Suppl 2):B51–2.
52.
go back to reference Nabergoj Makovec U, Horvat N, Kos M. The golden 2016: advanced medication review finally reimbursed. PCNE Newsl. 2016;11(4):3. Nabergoj Makovec U, Horvat N, Kos M. The golden 2016: advanced medication review finally reimbursed. PCNE Newsl. 2016;11(4):3.
53.
go back to reference Hajjar E, Cafiero A, Hanlon J. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345–51.CrossRef Hajjar E, Cafiero A, Hanlon J. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345–51.CrossRef
54.
go back to reference Sabate E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. Sabate E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
55.
go back to reference Lounsbery J, Green C, Bennett M, Pedersen C. Evaluation of pharmacists’ barriers to the implementation of medication therapy management services. JAPhA. 2009;49:51–8.PubMed Lounsbery J, Green C, Bennett M, Pedersen C. Evaluation of pharmacists’ barriers to the implementation of medication therapy management services. JAPhA. 2009;49:51–8.PubMed
56.
go back to reference Smith FJ. Chapter 10. Data collection: interviews and focus groups in conducting your pharmacy practice research project. 2nd ed. London: Pharmaceutical Press; 2010. Smith FJ. Chapter 10. Data collection: interviews and focus groups in conducting your pharmacy practice research project. 2nd ed. London: Pharmaceutical Press; 2010.
57.
go back to reference Whittemore R, Chase SK, Mandle CL. Validity in qualitative research. Qual Health Res. 2001;11(4):522–37.CrossRef Whittemore R, Chase SK, Mandle CL. Validity in qualitative research. Qual Health Res. 2001;11(4):522–37.CrossRef
Metadata
Title
Community pharmacists’ perspectives on implementation of Medicines Use Review in Slovenia
Authors
Urska Nabergoj Makovec
Mitja Kos
Nina Pisk
Publication date
01-10-2018
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 5/2018
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0644-6

Other articles of this Issue 5/2018

International Journal of Clinical Pharmacy 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine